DE3276433D1 - Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents - Google Patents

Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents

Info

Publication number
DE3276433D1
DE3276433D1 DE8282730152T DE3276433T DE3276433D1 DE 3276433 D1 DE3276433 D1 DE 3276433D1 DE 8282730152 T DE8282730152 T DE 8282730152T DE 3276433 T DE3276433 T DE 3276433T DE 3276433 D1 DE3276433 D1 DE 3276433D1
Authority
DE
Germany
Prior art keywords
sub
sup
substituted
novel
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282730152T
Other languages
English (en)
Inventor
Gregor Dr Haffer
Gerhard Dr Sauer
Helmut Dr Wachtel
Herbert Dr Schneider
Ulrich Dr Eder
Hans-Peter Dr Lorenz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE8282730152T priority Critical patent/DE3276433D1/de
Application granted granted Critical
Publication of DE3276433D1 publication Critical patent/DE3276433D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8282730152T 1981-12-23 1982-12-23 Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents Expired DE3276433D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8282730152T DE3276433D1 (en) 1981-12-23 1982-12-23 Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813151912 DE3151912A1 (de) 1981-12-23 1981-12-23 Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE8282730152T DE3276433D1 (en) 1981-12-23 1982-12-23 Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents

Publications (1)

Publication Number Publication Date
DE3276433D1 true DE3276433D1 (en) 1987-07-02

Family

ID=6150011

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19813151912 Withdrawn DE3151912A1 (de) 1981-12-23 1981-12-23 Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE8282730152T Expired DE3276433D1 (en) 1981-12-23 1982-12-23 Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19813151912 Withdrawn DE3151912A1 (de) 1981-12-23 1981-12-23 Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Country Status (18)

Country Link
US (1) US4826852A (de)
EP (2) EP0185392A3 (de)
JP (1) JPS58150593A (de)
AT (1) ATE27458T1 (de)
AU (1) AU570621B2 (de)
CA (1) CA1319684C (de)
CS (1) CS235098B2 (de)
DD (1) DD208619A5 (de)
DE (2) DE3151912A1 (de)
DK (1) DK163240C (de)
ES (1) ES8400115A1 (de)
GR (1) GR78410B (de)
HU (1) HU191623B (de)
IE (1) IE56541B1 (de)
IL (1) IL67545A (de)
RO (2) RO87945A (de)
SU (1) SU1313348A3 (de)
YU (1) YU282382A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400333A (nl) * 1983-02-16 1984-09-17 Sandoz Ag Moederkoornalkaloiden, hun bereiding en hun toepassing.
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3413657A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergoline
DE3413659A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 2-substituierte ergolin-derivate
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
DE3528576A1 (de) * 1985-08-06 1987-02-19 Schering Ag Verfahren zur herstellung von ergolin-thioharnstoffen
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
GB0307377D0 (en) * 2003-03-31 2003-05-07 Merad Pharmaceuticals Ltd Ergoline derivatives
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
CN101600417B (zh) * 2006-10-04 2012-05-30 M&P专利股份公司 用于神经递质的经鼻施用的控制释放递送系统
EP2083008A1 (de) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergolin-Derivate als selektive Radikalfänger für Neuronen
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533698A (en) * 1950-12-12 Urethanes containing the lysergic
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
DE1212097B (de) * 1962-09-05 1966-03-10 Sdruzeni Podnikuu Pro Zdravotn Verfahren zur Herstellung von N-[D-1, 6-Dimethylisoergolenyl-(8)]-N', N'-dialkylharnstoffen
FR1339406A (fr) * 1962-11-23 1963-10-04 Farmaceutici Italia Procédé de préparation de nouveaux dérivés de 6-méthylergoline pi et de 1, 6-diméthylergoline pi
BR6915443D0 (pt) * 1969-07-18 1973-03-13 Farmaceutici Italia Processo para a preparacao de derivados de ergolina
CH573937A5 (de) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
GB1573621A (en) * 1976-01-02 1980-08-28 Sandoz Ltd Acylated 6-methyl-8a-amino-ergoline i compounds
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
EP0021206B1 (de) * 1979-06-13 1983-06-22 Schering Aktiengesellschaft Neue (Ergolin-yl)-N', N'-diäthylharnstoff-Derivate, ihre Herstellung und sie enthaltende Arzneimittel
WO1982000463A1 (en) * 1980-07-25 1982-02-18 Ag Sandoz Ergoline derivatives,method for their preparation,pharmaceutical compositions containing them and their therapeutic application
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
GB2112382B (en) * 1981-11-06 1985-03-06 Erba Farmitalia Ergoline derivatives
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate

Also Published As

Publication number Publication date
IE56541B1 (en) 1991-08-28
CS955382A2 (en) 1984-02-13
SU1313348A3 (ru) 1987-05-23
ES518482A0 (es) 1983-11-01
DK163240C (da) 1992-06-29
AU570621B2 (en) 1988-03-24
JPS58150593A (ja) 1983-09-07
EP0185392A3 (de) 1987-05-13
RO85270A (ro) 1984-09-29
JPH0352463B2 (de) 1991-08-12
EP0082808A1 (de) 1983-06-29
CA1319684C (en) 1993-06-29
ES8400115A1 (es) 1983-11-01
DE3151912A1 (de) 1983-06-30
YU282382A (en) 1986-12-31
IE823051L (en) 1983-06-23
IL67545A (en) 1986-09-30
RO85270B (ro) 1984-10-30
CS235098B2 (en) 1985-04-16
DD208619A5 (de) 1984-04-04
GR78410B (de) 1984-09-27
IL67545A0 (en) 1983-05-15
ATE27458T1 (de) 1987-06-15
RO87945A (ro) 1986-09-30
HU191623B (en) 1987-03-30
EP0082808B1 (de) 1987-05-27
US4826852A (en) 1989-05-02
DK566982A (da) 1983-06-24
EP0185392A2 (de) 1986-06-25
DK163240B (da) 1992-02-10
AU9146882A (en) 1983-06-30

Similar Documents

Publication Publication Date Title
DE3276433D1 (en) Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents
ES8403897A1 (es) Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina
IL76625A0 (en) Substituted propane-phosphonous acid compounds
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
ES470155A1 (es) Un procedimiento para la obtencion de derivados de espiroa- mina
DE3567650D1 (en) 1,5-benzothiazephine derivatives, processes for preparing the same and pharmaceutical compositions
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
EP0153152A3 (de) (2-Oxo-1,2,3,5-tetrahydroimidazo[2,1-b]chinazolinyl)oxyalkylamide, ihre Herstellung, sie enthaltende Zusammensetzungen und ihre Verwendung bei der Herstellung von Medikamenten
GB2156345B (en) Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
AU575022B2 (en) Antiviral 5-halovinyl-2'-deoxyuridines
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
ES8400747A1 (es) "procedimiento para la preparacion de 2-mesitilimino-3-alcohil-3,4,6,7-tetrahidro-2h-pirimido(6,1-a)isoquinolein-4-onas sustituidas en 9,10".
EP0216323A3 (de) Derivate von Chinoloncarbonsäure und ihre Herstellung
EP0221541A3 (de) Chinolincarbonsäurederivate und ihre Herstellung
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ES8601931A1 (es) Procedimiento para preparar imidazoles y triazoles con es- tructura de enoleter
ES8202811A1 (es) Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina
ES8307790A1 (es) Un procedimiento para preparacion de 3-(2-(4-piperidil)-1-alquiletil) indoles.
IL85856A0 (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them
PH25608A (en) 3-amino-tetrahydro-isoquinoline

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AG, 13353 BERLIN, DE

8330 Complete renunciation